Showing results (81-90 of 95) with videos related to
Sort By:
Pageof 10
JAMA Network Open|January 3, 2023
Risk of Bias in Randomized Clinical Trials Comparing Transcatheter and Surgical Aortic Valve Replacement: A Systematic Review and Meta-analysisFabio Barili, James M Brophy, Daniele Ronco, et al.JAMA Cardiology|May 24, 2023
Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction: A Post Hoc Analysis of the EMPEROR-Preserved TrialJaved Butler, Muhammad Shariq Usman, Gerasimos Filippatos, et al.Journal of Cardiovascular Pharmacology and Therapeutics|September 25, 2003
A prospective, nonrandomized, open-labeled pilot study investigating the use of magnesium in patients undergoing nonacute percutaneous coronary intervention with stent implantationVladimir Rukshin, Raul Santos, Mitch Gheorghiu, et al.The American Journal of Cardiology|April 14, 2012
Waiting for the National Cholesterol Education Program Adult Treatment Panel IV Guidelines, and in the meantime, some challenges and recommendationsSeth S Martin, Thomas S Metkus, Aaron Horne, et al.Circulation|November 15, 2021
Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved TrialJaved Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi, et al.International Journal of Cardiology|June 26, 2025
Time-to-event analysis of the long-term outcome in trials comparing transcatheter and surgical aortic valve implantation: A meta-analysisFabio Barili, Francesco Pollari, Mateo Marin-Cuartas, et al.Circulation|September 13, 2022
Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection FractionJaved Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 24, 2024
Conflicts of interest in clinical practice: lessons learned from cardiovascular medicineDaniele Ronco, Arthur M Albuquerque, Mateo Marin-Cuartas, et al.Circulation|December 17, 2019
Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory IssuesJaved Butler, Milton Packer, Stephen J Greene, et al.The American Journal of Cardiology|July 18, 2006
From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force reportMorteza Naghavi, Erling Falk, Harvey S Hecht, et al.Pageof 10